MEDICINES Citation, commencement and interpretation 1 1 This Order may be cited as the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment (No. 2) Order 2001 and shall come into force on 10th December 2001. 2 In this Order— a “the principal Order ” means the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Order 1984 ; b “Table A of Schedule 1” means Table A (internal or external use) of Schedule 1 to the principal Order (which specifies the class of medicinal products, other than products the subject of a product licence of right, on general sale by virtue of article 2(a) of the principal Order); c “Table B of Schedule 1” means Table B (external use only) of Schedule 1 to the principal Order. Amendment of Table A of Schedule 1 to the principal Order 2 1 Table A of Schedule 1 is amended as follows— a against the entry for Ibuprofen , there is inserted— i in column 2, after the entry numbered “(2)”, the words “(3) 2.0 per cent”; ii in column 3, after the entry numbered “(2)”, the words “(3) Internal: liquid preparations, for the treatment of rheumatic or muscular pain, headache, dental pain, feverishness, or symptoms of colds and influenza for use in children aged under 12 years”; and iii in column 4, after the entry numbered “(2)”, the words “(3) 200 mg (MD) 800 mg (MDD)”; and b against the entry for Potassium Chloride — i in column 2, the entry “0.15 per cent” is numbered “(1)”; and ii in column 3, for the entry “Treatment of acute diarrhoea” there is substituted the entry “(1) Internal: for the treatment of acute diarrhoea” and, after that entry, there is inserted the entry “(2) External”. 2 In Table A of Schedule 1, there is inserted in column 1, at the appropriate place in the alphabetical order of the entries as they appear in that column, the entries set out in column 1 below, and, against those entries, there is inserted in columns 2, 3 and 4 the corresponding text in columns 2, 3 and 4 below: Column 1 Column 2 Column 3 Column 4 Substance Maximum strength or maximum amount released Use, pharmaceutical form or route of administration Maximum dose and maximum daily dose Cetirizine Hydrochloride 10 mg Tablets; for the symptomatic relief of perennial rhinitis, seasonal allergic rhinitis and idiopathic chronic urticaria in adults and in children aged 12 years and over 10 mg (MDD) Ibuprofen Lysine Equivalent to 200 mg ibuprofen Tablets; for the treatment of rheumatic or muscular pain, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness or symptoms of colds and influenza in adults and in children aged 12 years and over Equivalent to 400 mg ibuprofen (MD) Equivalent to 1200 mg ibuprofen (MDD) Loratadine 10 mg Tablets; for the symptomatic relief of perennial rhinitis, seasonal allergic rhinitis and idiopathic chronic urticaria in adults and in children aged 12 years and over 10 mg (MDD) Amendment of Table B of Schedule 1 to the principal Order 3 In Table B of Schedule 1— a there is deleted the entry “Potassium Chloride ” in column 1; and b against the entry Sodium Fluoride— i in column 2, the entry “0.33 per cent” is numbered “(1)” and, after that entry, there are inserted the entries “(2) 0.05 per cent”, and “(3) 0.2 per cent”; and ii in column 3, the entry “Dentifrice” is numbered “(1)” and, after that entry, there are inserted the entries “(2) Daily use mouth rinses for the prevention of dental caries”, and “(3) Mouth rinses for other than daily use for the prevention of dental caries”. Signed by authority of the Secretary of State for Health Hunt Parliamentary Under-Secretary of State, Department of Health 28th November 2001 Bairbre de Brún Minister of Health, Social Services and Public Safety 28th November 2001